AGP Executive Report
Last update: 9 hours agoEbola Response in Ituri: DRC expanded Ebola vaccination to Ituri, with 3,700+ people receiving Ervebo and a Bunia study (BRAVO) aiming to vaccinate about 20,000 frontline workers to test protection against the Bundibugyo strain. Ebola Toll Update: The outbreak is reported to have surpassed 3,700 deaths, with WHO warning many cases are detected only after people die in the community. Mpox Lab Results Questioned: Swiss-led research in The Lancet Infectious Diseases found about 35% of mpox PCR positives in several Congolese cities may reflect sample contamination, raising the risk of false diagnoses and misdirected surveillance. New Mpox Drug Trial: NanoViricides began a Phase II trial of NV-387 for mpox in the DRC, using an oral gummy formulation and enrolling first patients. Minerals, AI, and Power: KoBold Metals is using AI-directed exploration in the DRC to find critical minerals like lithium, as the race to reduce China’s dominance heats up. Conflict and Mining Abuses: Amnesty says M23 fighters abused artisanal miners and helped traffic gold and coltan to Rwanda, with violations that may amount to war crimes. Digital Payments Push: Visa named Congolese star Fally Ipupa as ambassador for Visa Pay in the DRC, tying the rollout to the country’s cashless agenda.**
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
